Date:February 12, 2026 Time:1:00 PM (Eastern Time) EDMUNDSTON, New Brunswick, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Acadian Timber Corp. will release its 2025 fourth quarter results after market close on Wednesday, February 11, 2026, which will be available on our website at www.acadiantimber.com/financial-information/. The release will be followed by a conference call and webcast on Thursday, February 12, 2026, at 1:00 p.m. (Eastern Time) to discuss with members of senior management our financial and op ...

Core Insights - Heidrick & Struggles has successfully transitioned to a privately held company through an acquisition led by Advent International and Corvex Private Equity, supported by a consortium of strategic investors [1][2][4] - The transaction is valued at approximately $1.3 billion and aims to facilitate a multi-year growth strategy for the company, marking a significant transformation in its 70-year history [2][4] - The company will continue to operate under its current brand and maintain its commitment to helping organizations build effective leadership teams [2][4] Company Leadership and Governance - Carmine Di Sibio, Operating Partner at Advent and former Global Chair and CEO of EY, will be appointed as Chairman of the Board of Managers [3] - The board will include Heidrick & Struggles CEO Tom Monahan, representatives from Advent, Corvex, strategic investors, and independent directors with expertise in leadership and global talent markets [3] Strategic Vision and Investment - The partnership is expected to enhance Heidrick & Struggles' growth strategy and solidify its position as a global leader in talent and advisory solutions [4] - Significant co-investment from Heidrick & Struggles leaders and partners is part of the transaction, supporting a new equity plan that aligns ownership with the company's ambitions [4] Market Impact - Following the completion of the transaction, Heidrick & Struggles' common stock has ceased trading on the Nasdaq Global Select Market [5]

Core Insights - Advent International's negotiations to acquire Whirlpool's India unit for up to $1 billion have failed due to valuation disagreements [1] Group 1 - The acquisition talks involved a potential deal valued at up to $1 billion [1] - The discussions collapsed after disagreements arose regarding the valuation of the India unit [1] - Four sources familiar with the matter confirmed the breakdown of the talks to Reuters [1]

Core Insights - Advent International has acquired a significant stake in NIQ Global Intelligence plc, amounting to 149,380,246 shares valued at approximately $2.35 billion, indicating a strong belief in the company's potential despite its current stock price being below its IPO level [1][2][9] Company Overview - NIQ Global Intelligence plc operates in the technology sector with over 38,000 employees globally, utilizing advanced analytics and artificial intelligence to provide consumer insights [5][8] - The company reported trailing twelve months (TTM) revenue of $4.01 billion and a net loss of $434.36 million as of September 30, 2025 [3][4] Financial Metrics - As of November 15, 2025, NIQ's stock price was $14.18, which is 30.46% below its 52-week high [3] - The company's market capitalization stands at $4.51 billion, with a forward P/E ratio of 23.06 and an enterprise value to EBITDA ratio of 15.37 [4][3] Investment Implications - Advent's investment represents 47.23% of its reportable U.S. equity holdings, making NIQ its largest holding [3][6] - The concentration of investment in NIQ suggests that Advent believes there is significant value that the market has yet to recognize [9] Market Position - NIQ plays a crucial role in providing measurement systems for global brands to understand consumer purchasing behavior, which is essential for strategic decision-making [10][11] - The company faces challenges related to leverage and integration costs, which may impact its financial stability, but it remains a vital intelligence resource for consumer companies [11]

Revenue and Contracts - Advent's revenue primarily comes from the sale and servicing of fuel cell systems and Membrane Electrode Assemblies (MEAs), with expectations for significant future income from these markets [185]. - The company secured a €34.5 million grant from the EU Innovation Fund for the RHyno Project, aimed at developing innovative fuel cells and electrolysers [204]. - Advent secured a new $2.2 million contract with the US DoD in September 2023 to optimize the Honey Badger 50™ portable fuel cell system [212]. - In December 2023, Advent obtained a $2.8 million contract with the US DoD to develop advanced manufacturing processes for the HB50 system [213]. - Advent expects to continue receiving grant funding for product development activities in the foreseeable future [185]. - Revenues are expected to increase materially, with a focus on Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) [227]. Financial Performance - Total revenue decreased by approximately $66 thousand from $128 thousand in Q3 2024 to $62 thousand in Q3 2025, a decline of 51.6% [239]. - Total revenue decreased by approximately $3.2 million from $3.5 million in the nine months ended September 30, 2024 to $0.3 million in the nine months ended September 30, 2025, a decline of 91.7% [248]. - Cost of revenues increased by approximately $101 thousand from $336 thousand in Q3 2024 to $437 thousand in Q3 2025, an increase of 30.1% [240]. - Gross loss increased by approximately $167 thousand from a loss of $208 thousand in Q3 2024 to a loss of $375 thousand in Q3 2025, an increase of 80.3% [238]. - Income from grants increased by approximately $38 thousand from $137 thousand in Q3 2024 to $175 thousand in Q3 2025, an increase of 27.7% [241]. - Operating loss decreased by approximately $5.6 million from a loss of $7.9 million in Q3 2024 to a loss of $2.4 million in Q3 2025, a decrease of 70.1% [238]. - Research and development expenses decreased by approximately $182 thousand from $411 thousand in Q3 2024 to $229 thousand in Q3 2025, a decrease of 44.3% [242]. - Administrative and selling expenses decreased by approximately $1.2 million from $3.1 million in Q3 2024 to $2.0 million in Q3 2025, a decrease of 37.2% [243]. - For the nine months ended September 30, 2025, net income was $(1) thousand compared to $0.1 million in 2024, indicating a decrease of $0.1 million [288]. - The net loss from continuing operations for the three months ended September 30, 2025, was $8.62 million, a change of $18.23 million from a loss of $9.61 million in 2024 [296]. - EBITDA for the three months ended September 30, 2025, was $(2.22) million, improving by $5.54 million from $(7.76) million in 2024 [296]. - Adjusted EBITDA for the nine months ended September 30, 2025, was $(7.67) million, a change of $13.45 million from $(21.13) million in 2024 [296]. Cash Flow and Liquidity - The Company reported a net cash used in operating activities of approximately $(0.9) million for the nine months ended September 30, 2025, compared to $3.1 million for the same period in 2024, reflecting a decrease of $3.983 million or 129.0% [264]. - Cash flows from investing activities were approximately $(30) thousand for the nine months ended September 30, 2025, down from $0.3 million in 2024, representing a decrease of $302 thousand or 111.0% [265]. - The Company generated net cash provided by financing activities of approximately $2.1 million for the nine months ended September 30, 2025, compared to $0.3 million in 2024, an increase of $1.836 million or 651.1% [266]. - The total cash and cash equivalents at the end of the period were $468 thousand for September 30, 2025, up from $192 thousand in 2024, marking an increase of $276 thousand or 143.8% [262]. - The Company had a working capital deficit of $(16.0) million as of September 30, 2025, with $0.5 million in cash and cash equivalents [259]. - The Company experienced a cash shortfall that could impact its ability to meet current obligations, potentially leading to liquidation actions by creditors [260]. - The Company recognized contract assets of $0.6 million as of September 30, 2025, consistent with the amount recognized as of December 31, 2024 [271]. - The Company reported a net decrease in cash, cash equivalents, and restricted cash of $1.193 million for the nine months ended September 30, 2025, compared to a decrease of $3.642 million in 2024, indicating a reduction of $2.449 million or 67.2% [262]. Debt and Financing - Advent entered into a term loan agreement for $1.465 million with an effective interest rate of 206% per year, requiring weekly payments of $45-66 thousand until February 27, 2026 [189]. - The company has made repayments totaling $140 thousand and $185 thousand during the three and nine months ended September 30, 2025, on its term loan [189]. - Advent had an unrestricted cash balance of approximately $0.5 million as of September 30, 2025, with short-term debt of $1.8 million [298]. Research and Development - The company launched the Honey Badger 50™ Fuel Cell System, capable of generating up to 50W of continuous power, with a weight savings of 65% compared to traditional batteries [209]. - A joint benchmarking project with Airbus aims to optimize the Ion Pair™ MEA for hydrogen fuel cells, with financial support from Airbus and a multi-million-dollar investment from Advent [207]. - Advent's MEA technology is designed to enhance performance and reduce costs, contributing to the company's competitive advantage in the fuel cell market [183]. - The company is developing its next generation MEA technology, expected to deliver up to three times the power output of its current product [225]. - Research and development expenses are projected to increase substantially as Advent invests in improved technology and products [230]. Operational Challenges - The Company has substantial doubt regarding its ability to continue as a going concern for one year from the date the consolidated financial statements are issued due to a lack of positive cash flow and liquidity [260]. - The Company’s cash flows from operating activities are expected to be affected by increased working capital needs as it grows [263]. - Advent does not believe inflation currently has a material effect on its business and is taking steps to mitigate cost increases [299]. Tax and Regulatory Matters - Advent is subject to income tax examinations by major taxing authorities, with the U.S. corporate income tax rate reduced from 35% to 21% under the Tax Cuts and Jobs Act of 2017 [289]. - The company recorded a fair value adjustment for Private Placement Warrants and Working Capital Warrants, which are classified as liabilities [290]. - Advent has not entered into any hedging transactions for foreign exchange risk, despite having costs and revenues denominated in Euros [300]. - The company recorded a change in fair value of warrant liability amounting to nil for the three months ended September 30, 2025 [233]. - The company recorded an income tax expense of $(1) thousand for the nine months ended September 30, 2025, mainly related to net operating loss carryforwards [236].

Core Insights - Kraft Natural Cheese has launched its first-ever Holiday Advent Calendar, designed to foster family connections through cheese-inspired surprises [2][3][5] Product Details - The Holiday Advent Calendar stands over a foot tall and features 12 pull-out drawers, each containing curated surprises that celebrate cooking and sharing meals [3] - The retail value of the Advent Calendar is $250, and it includes kitchen keepsakes and digital recipes accessible via QR codes [3] Marketing and Events - Kraft Natural Cheese will host a festive immersive pop-up experience at Chicago's Christkindlmarket from December 10–13, where visitors can enjoy cheese samples and win prizes [4] - The Marketing Director of Lactalis Heritage Dairy expressed the brand's aim to spread holiday cheer through unique celebrations and traditions [5] Company Background - Kraft Natural Cheese has been a trusted name since 1904, known for its quality and flavor in natural cheeses [6] - The brand is part of Lactalis Heritage Dairy, which boasts over 150 years of combined dairy experience [6]

Company Performance - Advent Technologies Holdings, Inc. (NASDAQ:ADN) experienced a price drop to $1.065, marking a 60.70% decrease, indicating challenges in the fuel cell and hydrogen technology markets [1][7] - Fiserv, Inc. (NASDAQ:FI) saw its price fall to $72.59, a 42.46% decrease, reflecting potential challenges within the fintech sector and competitive pressures [2][7] - Stride, Inc. (NYSE:LRN) witnessed a sharp price decrease to $75.07, translating to a 51.10% drop, possibly due to concerns over growth prospects and operational challenges [3] - Quhuo Limited (NASDAQ:QH) faced a dramatic decline to $1.78, a decrease of 78.06%, which may indicate market apprehensions about regulatory challenges or operational inefficiencies [4][7] - Varonis Systems, Inc. (NASDAQ:VRNS) saw its price decrease to $34.58, marking a 45.11% fall, reflecting concerns over cybersecurity market competition and shifts in enterprise spending [5] Market Trends - The significant price movements among these companies highlight the importance of monitoring market trends, company-specific news, and broader economic indicators [6]

Core Insights - Advent Technologies Holdings, Inc. is advancing the electrification of aviation through high-temperature proton exchange membrane fuel cells (HT-PEM FCs) in collaboration with aerospace partners [1][2] - The company’s proprietary Ion Pair™ membrane electrode assembly (MEA) enhances power output and thermal management efficiency, crucial for sustainable aviation [2][5] - Advent's HT-PEM technology allows for lighter and more compact aircraft designs, leading to improved performance and reduced operational costs [3][6] Company Overview - Advent Technologies is a leader in fuel cell and hydrogen technology, headquartered in Livermore, California, with a focus on renewable energy applications [1][6] - The company holds approximately 70 patents related to fuel cell technology, enabling high-temperature operations suitable for various sectors including aviation [6] Industry Context - Over 100 companies are engaged in developing electric flight solutions, with Advent providing essential technology for hydrogen-powered flight [2] - Stralis Aircraft, a partner of Advent, is pioneering hydrogen-powered fixed-wing aircraft, emphasizing the importance of advanced cooling systems for electric flight [3][4] - Liquid hydrogen offers a significant energy density advantage (approximately 33.3 kWh/kg) over lithium-ion batteries (around 0.3 kWh/kg), making it more suitable for long-range aviation applications [4]

Core Insights - Advent Technologies Holdings, Inc. has officially partnered with Arxicon for the RHyno Project, aimed at developing innovative fuel cell and electrolyser manufacturing facilities in Greece [1][2][3] Group 1: Project Overview - The RHyno Project commenced on April 1, 2025, and is funded by the EU Innovation Fund, with a total non-dilutive grant of €34.5 million allocated to Advent [2] - The project focuses on manufacturing advanced fuel cells and electrolysers, utilizing Advent's Membrane Electrode Assembly (MEA) technology at a megawatt scale, enhancing power density and lifespan while reducing weight and volume [2] Group 2: Strategic Importance - The RHyno Project is positioned to reinforce Advent's leadership in the fuel cell market and marks its strategic entry into the electrolyser sector, contributing to Europe's clean energy transition [2][3] - The collaboration is seen as a pivotal moment for Greece in leading Europe's hydrogen economy and securing energy independence [3] Group 3: Company Background - Advent Technologies is a U.S. corporation specializing in the development and manufacturing of fuel cell systems and components, holding over 70 patents in fuel cell technology [4] - Arxicon, with extensive experience in delivering complex infrastructure projects globally, has completed over €500 million in projects since 2000, making it a valuable partner for the RHyno Project [5]

Core Points - Northwest Biotherapeutics, Inc. has successfully closed the acquisition of Advent BioServices Ltd., making Advent a wholly owned subsidiary [1][2] - The acquisition is expected to enhance operational efficiencies and scale-up capabilities for the company [2][5] - The company will not issue any new shares for the acquisition; instead, 19 million NWBio securities previously issued to Advent will revert back to the company [3][4] Financial Details - The acquisition consideration includes a payment of £1.4 million and the net amount of accounts payable already due from the company to Advent [4] - Payments for the acquisition will be made in installments over two years, starting 90 days after the closing date [4] Strategic Implications - The integration of Advent is anticipated to accelerate the development of additional applications and next-generation technologies [5] - The acquisition will facilitate a fully integrated platform combining the technologies and intellectual property of both companies, leading to streamlined operations and enhanced manufacturing capacity [8] Company Overview - Northwest Biotherapeutics focuses on developing personalized immunotherapy products for cancer treatment, particularly through its DCVax® platform [6] - The company has completed a Phase III trial for its DCVax-L treatment for glioblastoma and is currently awaiting regulatory approval in the UK [6]